ADHD Med Exposure in Utero Not Tied to Long-Term Impact in Offspring
FRIDAY, Feb. 24, 2023 (HealthDay News) — Neurodevelopment and growth in offspring is not negatively impacted by prenatal exposure to attention-deficit/hyperactivity disorder (ADHD) medication, according to a study published online Feb. 9 in Molecular…
Learn MoreU.S. to Allow Medicaid to Pay for Drug Treatment in Prisons
WEDNESDAY, Feb. 22, 2023 (HealthDay News) — Soon, the federal government will allow states to use Medicaid funds to treat prisoners for drug addiction and mental health services.In an announcement made during a visit to the Camden County Jail in New …
Learn MoreMethotrexate Linked to Increased Risk for Skin Cancer
WEDNESDAY, Feb. 22, 2023 (HealthDay News) — Methotrexate is associated with an increased risk for skin cancer, with evidence of a dose-response pattern, according to a study published online Feb. 4 in the British Journal of Cancer.Sam Polesie, M.D., …
Learn MoreSkin Sensitivity Can ID Responders to Galcanezumab for Migraine Prevention
TUESDAY, Feb. 21, 2023 (HealthDay News) — The presence or absence of nonictal allodynia can be used to identify migraine sufferers who will likely respond to galcanezumab, according to a study published online Feb. 14 in Cephalalgia.Sait Ashina, M.D….
Learn MoreRucaparib Efficacious in Metastatic Castration-Resistant Prostate Cancer
FRIDAY, Feb. 17, 2023 (HealthDay News) — For patients with metastatic castration-resistant prostate cancer, treatment with rucaparib is associated with significantly longer duration of imaging-based progression-free survival compared with a control m…
Learn MoreTalazoparib + Enzalutamide Beneficial in Metastatic Prostate Cancer
FRIDAY, Feb. 17, 2023 (HealthDay News) — For patients with metastatic castration-resistant prostate cancer (mCRPC), treatment with talazoparib (TALA) plus enzalutamide (ENZA) is better than placebo (PBO) plus ENZA, according to a study presented at t…
Learn MoreSleep Meds Tied to Higher Dementia Risk in White Older Adults
THURSDAY, Feb. 16, 2023 (HealthDay News) — Frequent sleep medication use is associated with an increased risk for dementia in White older adults, according to a study published online Jan. 31 in the Journal of Alzheimer’s Disease.Yue Leng, Ph.D., fro…
Learn MoreDrugs With Low Clinical Benefit Show Higher Direct-to-Consumer Spending
WEDNESDAY Feb. 15, 2023 (HealthDay News) — Among the top-selling U.S. drugs, those with lower added clinical benefit ratings and higher total drug sales have higher manufacturer spending on direct-to-consumer advertising, according to a study publish…
Learn MoreTexas Lawsuit Threatens Access to Abortion Pill Nationally
MONDAY, Feb. 13, 2023 (HealthDay News) — Access to medication abortion could be at risk nationwide because of a Texas lawsuit working its way through the court system. Alliance Defending Freedom, the group involved in the case in Mississippi that led…
Learn MoreIde-Cel Beneficial in Relapsed, Refractory Multiple Myeloma
FRIDAY, Feb. 10, 2023 (HealthDay News) — For patients with pretreated relapsed and refractory multiple myeloma, idecabtagene vicleucel (ide-cel), a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy, prolongs progression-free…
Learn More